Barone Giancarlo, Groom Alix, Reiman Anne, Srinivasan Venkataramanan, Byrd Philip J, Taylor A Malcolm R
Cancer Research-UK Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Hum Mutat. 2009 Aug;30(8):1222-30. doi: 10.1002/humu.21034.
Ataxia-telangiectasia mutated (ATM) is the gene mutated in the cancer-predisposing disorder ataxia-telangiectasia (A-T). We modeled ATM sequence variants identified in UK A-T patients to determine the stability and kinase activity of the resulting proteins as well as the distribution of these mutations across the coding region. Of 20 missense changes modeled, 10 proteins showed ATM kinase activity and 10 showed none. In the majority of cases the mutant ATM protein was unstable, although this was variable. Reduction in ATM kinase activity can result either from the presence of low levels of unstable mutant protein with relatively normal specific kinase activity or from stable mutant protein with deficient ATM kinase activation. Indeed, ATM mutant proteins without kinase activity toward downstream targets were still able to autophosphorylate on serine 1981, although in a much less efficient manner, suggesting that this was not sufficient for ATM activation. In terms of function, green fluorescent protein (GFP)-tagged kinase inactive ATM proteins could form ionizing radiation (IR)-induced foci (IRIF), at least temporarily, which colocalized with the DNA double-strand break (DSB) marker gammaH2AX. Consistent with this, both kinase active and inactive mutant ATM proteins were able to interfere with phosphorylation of targets by endogenous ATM. Since the majority of missense mutations occurred C-terminal to aa1966, including all 10 mutations with absence of kinase activity, the implication was that mutations N-terminal to this, with exceptions, are less likely to result in loss of kinase activity and therefore, are less likely to be identified in A-T patients.
共济失调毛细血管扩张症突变基因(ATM)是在癌症易感疾病共济失调毛细血管扩张症(A-T)中发生突变的基因。我们对在英国A-T患者中鉴定出的ATM序列变异进行建模,以确定所得蛋白质的稳定性和激酶活性,以及这些突变在编码区域的分布。在建模的20个错义变化中,10种蛋白质显示出ATM激酶活性,10种则未显示。在大多数情况下,突变的ATM蛋白不稳定,尽管存在差异。ATM激酶活性的降低可能是由于存在低水平的不稳定突变蛋白且具有相对正常的特异性激酶活性,或者是由于稳定的突变蛋白具有缺陷的ATM激酶激活。实际上,对下游靶点无激酶活性的ATM突变蛋白仍能够在丝氨酸1981处进行自磷酸化,尽管效率要低得多,这表明这不足以激活ATM。在功能方面,绿色荧光蛋白(GFP)标记的激酶无活性的ATM蛋白至少在暂时情况下能够形成电离辐射(IR)诱导的病灶(IRIF),其与DNA双链断裂(DSB)标记γH2AX共定位。与此一致的是,激酶活性和无活性的突变ATM蛋白都能够干扰内源性ATM对靶点的磷酸化。由于大多数错义突变发生在第1966位氨基酸的C末端,包括所有10个无激酶活性的突变,这意味着在此之前的N末端突变,除了个别情况外,不太可能导致激酶活性丧失,因此,在A-T患者中不太可能被发现。